Jumat, 17 Februari 2023

Google Alert - Business

Google
Business
Daily update February 18, 2023
NEWS
Kiplinger's Personal Finance
Altogether, they will reshape how millions of Americans plan for retirement, including older adults stuffing away extra money in their nest eggs and those struggling to pay off student debt.
Facebook Twitter Flag as irrelevant
Polsky Center for Entrepreneurship and Innovation
The Polsky Center hosted the 22nd annual BPOC Private Equity Conference February 3, 2023, at the Chicago Marriott Downtown. Keynote speaker David Rubenstein, JD '73 (left) was joined in conversation with UChicago Professor Steve Kaplan (right). (Photo by ...
Facebook Twitter Flag as irrelevant
CNET
The Justice Department, together with the Federal Trade Commission (FTC), today announced a civil enforcement action against several corporate and individual defendants for alleged violations of the FTC Act and the Telemarketing Sales Rule (TSR) in ...
Facebook Twitter Flag as irrelevant
U.S News & World Report Money
In connection with the shortened settlement timeline, the final rule also adds procedural requirements on broker-dealers relating to allocations, confirmations and affirmations, as well as record-keeping requirements for registered investment advisers.
Facebook Twitter Flag as irrelevant
michigan.gov
Steve Noble, EGLE's electronics recycling coordinator, also advises battery customers to consider lithium or rechargeable batteries to extend battery life and reduce waste. Today is National Battery Day. Every year in the United States, ...
Facebook Twitter Flag as irrelevant
wsgr.com
February 17, 2023. The Daily Journal recognized three Gibson Dunn wins in its annual feature on the Top Verdicts in California for 2022. The publication named Burton v. Campbell et al., Ortiz v. Amazon.com and Persian Gulf Inc. v.
Facebook Twitter Flag as irrelevant
PRNewswire
The results of PROpel are important for patients and the oncology community alike, providing support for this combination as a potential and critically needed new treatment option in metastatic castration-resistant prostate cancer." Susan Galbraith ...
Facebook Twitter Flag as irrelevant
ACROFAN USA
PD-1 inhibitors in combination with chemo have shown efficacy in G/GEJ cancer. We present results of the double-blind, placebo-controlled KEYNOTE-859 study of pembro + fluoropyrimidine- and platinum-containing chemo for advanced HER2-negative G/GEJ cancer ...
Facebook Twitter Flag as irrelevant
See more results | Edit this alert
You have received this email because you have subscribed to Google Alerts.
RSS Receive this alert as RSS feed
Send Feedback

Tidak ada komentar:

Posting Komentar